GenePlanet “National Winner” in prestigious European competition

24 September 2019

GenePlanet has been named National Winner in the 2019 European Business Awards, one of the world’s largest business competitions. 

The company was chosen from 2,753 businesses named as Ones to Watch in a list of business excellence published in July. Now a panel of independent judges including business leaders, politicians, and academics, has selected GenePlanet as a National Winner, making it the best business in Slovenia in the category Award for Growth Strategy of the Year. 

 In a decade, GenePlanet has grown into one of the leading European biotech companies, utilizing the latest achievements in the fields of genetics and bioinformatics to create innovative preventive healthcare solutions for the general public. 

 GenePlanet CEO Marko Bitenc is very satisfied with the outcome“European Business Awards is an authority in the field, and this recognition comes as a strong motivation for the entire company to continue pushing the boundaries between science and business with a goal of helping people live better. 

Adrian Tripp, CEO of the European Business Awards, said: “This is a significant achievement, and GenePlanet is an outstanding leader in their field. To be chosen as a National Winner means you show great innovation, ethics and success and are one of the best businesses in Europe. We wish GenePlanet the best of luck in the final round.” 

 The final round of judging will take place in Warsaw, Poland on the 3rd and 4th of December, along with a Summit to engage in business issues and the Gala Ceremony where the overall category winners for the 2019 European Business Awards will be announced. 

 The European Business Awards is now in its 12th year, and its primary purpose is to support the development of a stronger and more successful business community throughout Europe. This year it considered over 120,000 businesses from 33 countries. Sponsors and partners include Inflexion, Germany Trade & Invest and Cision PR Newswire.